Advertisement

Journal of Clinical Immunology

, Volume 38, Issue 3, pp 278–282 | Cite as

Mendelian Susceptibility to Mycobacterial Disease Caused by a Novel Founder IL12B Mutation in Saudi Arabia

  • Abdulrahman N. Alodayani
  • Abdulnasir M. Al-Otaibi
  • Caroline Deswarte
  • Husn Habib Frayha
  • Matthieu Bouaziz
  • Maryam AlHelale
  • Tom Le Voyer
  • Alejandro Nieto-Patlan
  • Vimel Rattina
  • Mofareh AlZahrani
  • Rabih Halwani
  • Fahad Al Sohime
  • Hamoud Al-Mousa
  • Saleh Al-Muhsen
  • Sami H. Alhajjar
  • Nabil S. Dhayhi
  • Laurent Abel
  • Jean-Laurent Casanova
  • Ibrahim Bin-Hussain
  • May S. AlBarrak
  • Suliman A. Al-Jumaah
  • Jacinta Bustamante
Original Article

Abstract

Purpose

Mendelian susceptibility to mycobacterial disease (MSMD) is a rare primary immunodeficiency predisposing congenitally affected individuals to diseases caused by weakly virulent mycobacteria, such as Bacillus Calmette-Guérin (BCG) vaccine strains and environmental mycobacteria. IL-12p40 deficiency is a genetic etiology of MSMD resulting in impaired IL-12- and IL-23-dependent IFN-γ immunity. Most of the reported patients with IL-12p40 deficiency originate from Saudi Arabia (30 of 52) and carry the recurrent IL12B mutation c.315insA (27 of 30).

Methods

Whole-exome sequencing was performed on three patients from two unrelated kindreds from Saudi Arabia with disseminated disease caused by a BCG vaccine substrain.

Results

Genetic analysis revealed a homozygous mutation, p.W60X, in exon 3 of the IL12B gene, resulting in complete IL12p40 deficiency. This mutation is recurrent due to a new founder effect.

Conclusions

This report provides evidence for a second founder effect for recurrent mutations of IL12B in Saudi Arabia.

Keywords

Mendelian susceptibility to mycobacterial disease Bacillus Calmette-Guérin (BCG) disseminated BCG infection, IL-12, interferon 

Notes

Acknowledgements

We thank the patients and their families for participating in this study. We thank Yelena Nemirovskaya, Cécile Patissier, and Céline Desvallées for technical and secretarial assistance, and all members of the Laboratory of Human Genetics of Infectious Diseases for helpful discussions.

Financial Support

The Laboratory of Human Genetics of Infectious Diseases is supported by grants from the St. Giles Foundation, the Jeffrey Modell Foundation, The Rockefeller University Center for Clinical and Translational Science grant number 8UL1TR000043 from the National Center for Research Resources and the National Center for Advancing Sciences (NCATS), the National Institutes of Health, the National Institute of Allergy and Infectious Diseases grant number 5R01AI089970-02, The Rockefeller University, and the European Research Council (ERC), the Integrative Biology of Emerging Infectious Diseases Laboratory of Excellence (ANR-10-LABX-62-IBEID) and the French National Research Agency (ANR) under the “Investments for the future” program (grant number ANR-10-IAHU-01), ANR-GENMSMD (ANR-16-CE17-0005-01). F.A.S. is supported by Dallah Heathcare grant.

Compliance with Ethical Standards

Conflict of Interest

The authors declare that they have no conflict of interest.

Research Involving Human Participants

Informed consent for participation in this study was obtained in accordance with local regulations, with approval from the IRB. The experiments described here were performed in France, in accordance with local regulations, and with the approval of the IRB of Necker Hospital for Sick Children, France.

Informed Consent

Written informed consent was obtained from the patients.

Supplementary material

10875_2018_490_MOESM1_ESM.docx (13 kb)
Supplementary table 1 (DOCX 13 kb)

References

  1. 1.
    Al-Saud B, Al-Mousa H, Al Gazlan S, Al-Ghonaium A, Arnaout R, Al-Seraihy A, et al. Primary immunodeficiency diseases in Saudi Arabia: a tertiary care hospital experience over a period of three years (2010-2013). J Clin Immunol. 2015;35(7):651–60.CrossRefPubMedGoogle Scholar
  2. 2.
    Al-Muhsen S, Alsum Z. Primary immunodeficiency diseases in the Middle East. Ann N Y Acad Sci. 2012;1250:56–61.CrossRefPubMedGoogle Scholar
  3. 3.
    Al-Muhsen S, Casanova JL. The genetic heterogeneity of Mendelian susceptibility to mycobacterial diseases. J Allergy Clin Immunol. 2008;122(6):1043–51. quiz 52-3CrossRefPubMedGoogle Scholar
  4. 4.
    Al-Mousa H, Abouelhoda M, Monies DM, Al-Tassan N, Al-Ghonaium A, Al-Saud B, et al. Unbiased targeted next-generation sequencing molecular approach for primary immunodeficiency diseases. J Allergy Clin Immunol. 2016;137(6):1780–7.CrossRefPubMedGoogle Scholar
  5. 5.
    Bustamante J, Boisson-Dupuis S, Abel L, Casanova JL. Mendelian susceptibility to mycobacterial disease: genetic, immunological, and clinical features of inborn errors of IFN-gamma immunity. Semin Immunol. 2014;26(6):454–70.CrossRefPubMedPubMedCentralGoogle Scholar
  6. 6.
    Casanova JL, Abel L. Genetic dissection of immunity to mycobacteria: the human model. Annu Rev Immunol. 2002;20:581–620.CrossRefPubMedGoogle Scholar
  7. 7.
    Kreins AY, Ciancanelli MJ, Okada S, Kong XF, Ramirez-Alejo N, Kilic SS, et al. Human TYK2 deficiency: mycobacterial and viral infections without hyper-IgE syndrome. J Exp Med. 2015;212(10):1641–62.CrossRefPubMedPubMedCentralGoogle Scholar
  8. 8.
    Altare F, Lammas D, Revy P, Jouanguy E, Doffinger R, Lamhamedi S, et al. Inherited interleukin 12 deficiency in a child with bacille Calmette-Guerin and Salmonella enteritidis disseminated infection. J Clin Invest. 1998;102(12):2035–40.CrossRefPubMedPubMedCentralGoogle Scholar
  9. 9.
    Picard C, Fieschi C, Altare F, Al-Jumaah S, Al-Hajjar S, Feinberg J, et al. Inherited interleukin-12 deficiency: IL12B genotype and clinical phenotype of 13 patients from six kindreds. Am J Hum Genet. 2002;70(2):336–48.CrossRefPubMedGoogle Scholar
  10. 10.
    Prando C, Samarina A, Bustamante J, Boisson-Dupuis S, Cobat A, Picard C, et al. Inherited IL-12p40 deficiency: genetic, immunologic, and clinical features of 49 patients from 30 kindreds. Medicine (Baltimore). 2013;92(2):109–22.CrossRefGoogle Scholar
  11. 11.
    Ben-Mustapha I, Ben-Ali M, Mekki N, Patin E, Harmant C, Bouguila J, et al. A 1,100-year-old founder effect mutation in IL12B gene is responsible for Mendelian susceptibility to mycobacterial disease in Tunisian patients. Immunogenetics. 2014;66(1):67–71.CrossRefPubMedGoogle Scholar
  12. 12.
    Parvaneh N, Barlogis V, Alborzi A, Deswarte C, Boisson-Dupuis S, Migaud M, et al. Visceral leishmaniasis in two patients with IL-12p40 and IL-12Rbeta1 deficiencies. Pediatr Blood Cancer 2017;64:e26362.Google Scholar
  13. 13.
    Alaki EM, Aljobair F, Alaklobi F, Al Shamrani M, Al-Zahim F, Dongues A, et al. Chronic disseminated salmonellosis in a patient with interleukin-12p40 deficiency. Pediatr Infect Dis J 2018;37(1):90–93.Google Scholar
  14. 14.
    Genin E, Tullio-Pelet A, Begeot F, Lyonnet S, Abel L. Estimating the age of rare disease mutations: the example of Triple-A syndrome. J Med Genet. 2004;41(6):445–9.CrossRefPubMedPubMedCentralGoogle Scholar
  15. 15.
    Mansouri D, Adimi P, Mirsaeidi M, Mansouri N, Khalilzadeh S, Masjedi MR, et al. Inherited disorders of the IL-12-IFN-gamma axis in patients with disseminated BCG infection. Eur J Pediatr. 2005;164(12):753–7.CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2018

Authors and Affiliations

  • Abdulrahman N. Alodayani
    • 1
  • Abdulnasir M. Al-Otaibi
    • 1
  • Caroline Deswarte
    • 2
    • 3
  • Husn Habib Frayha
    • 4
  • Matthieu Bouaziz
    • 2
    • 3
  • Maryam AlHelale
    • 1
  • Tom Le Voyer
    • 2
    • 3
  • Alejandro Nieto-Patlan
    • 2
    • 3
  • Vimel Rattina
    • 2
    • 3
  • Mofareh AlZahrani
    • 5
  • Rabih Halwani
    • 4
    • 6
  • Fahad Al Sohime
    • 6
  • Hamoud Al-Mousa
    • 4
  • Saleh Al-Muhsen
    • 4
    • 6
  • Sami H. Alhajjar
    • 4
  • Nabil S. Dhayhi
    • 7
  • Laurent Abel
    • 2
    • 3
    • 8
  • Jean-Laurent Casanova
    • 2
    • 3
    • 8
    • 9
    • 10
  • Ibrahim Bin-Hussain
    • 4
  • May S. AlBarrak
    • 1
  • Suliman A. Al-Jumaah
    • 4
  • Jacinta Bustamante
    • 2
    • 3
    • 8
    • 11
  1. 1.Division of Infectious Diseases, Department of PediatricsPrince Sultan Military Medical CityRiyadhSaudi Arabia
  2. 2.Laboratory of Human Genetics of Infectious Diseases, Necker Branch, INSERM U1163, Imagine InstituteNecker Hospital for Sick ChildrenParisFrance
  3. 3.Paris Descartes UniversityParisFrance
  4. 4.Department of PediatricsKing Faisal Specialist Hospital and Research CenterRiyadhSaudi Arabia
  5. 5.Section of Pediatric, Allergy and Immunology, Children Specialized HospitalKing Faisal Specialist Hospital & Research CenterRiyadhSaudi Arabia
  6. 6.Immunology Research Laboratory, College of MedicineKing Saud UniversityRiyadhSaudi Arabia
  7. 7.Department of PediatricsKing Fahad Specialist HospitalGizanSaudi Arabia
  8. 8.St. Giles Laboratory of Human Genetics of Infectious Diseases, Rockefeller BranchThe Rockefeller UniversityNew York CityUSA
  9. 9.Howard Hughes Medical InstituteNew York CityUSA
  10. 10.Pediatric Hematology-Immunology Unit, Assistance Publique-Hôpitaux de Paris AP-HPNecker Hospital for Sick ChildrenParisFrance
  11. 11.Center for the Study of Primary Immunodeficiencies, Assistance Publique-Hôpitaux de Paris AP-HPNecker Hospital for Sick ChildrenParisFrance

Personalised recommendations